Foley Partner Michele Simkin and former Foley attorney Todd Spalding byline “How Will Patents Impact the Commercialization of Stem Cell Therapeutics,” appeared in the October issue of the Journal of Pharmaceutical Innovation.
Author(s)
Related Insights
14 June 2024
Events
Data Privacy & Information Security: The Evolving Regulatory Landscape & How Companies Are Dealing With It
Join the American Resort Development Association and the University of Florida Levin College of Law for a joint legal symposium on the issues facing the timeshare and hospitality industries.
24 April 2024
Legal News: Environmental
U.S. EPA Finalizes Designation of Two PFAS Chemicals as Hazardous Substances Under CERCLA
On April 19, the U.S. Environmental Protection Agency released its long-awaited final rule designating perfluorooctanoic acid and perfluorooctanesulfonic acid, including their salts and structural isomers, as “hazardous substances” under Section 102(a) of the Comprehensive Environmental Response, Compensation, and Liability Act.
24 April 2024
Foley Career Perspectives
Washington, D.C. Office Managing Partner David Sanders Offers Insights for Aspiring General Counsel
Foley’s clients entrust our firm to look beyond the law to deliver holistic business solutions for their most challenging problems.